Recruiting × Neuroendocrine Tumors × Gastrointestinal × Clear all SUR-CAN
Phase 2 Recruiting
88 enrolled
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Phase 2 Recruiting
740 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
INDIGO
Phase NA Recruiting
51 enrolled
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Phase 1/2 Recruiting
135 enrolled
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 Recruiting
27 enrolled
F-Tryptophan PET/CT in Human Cancers
Phase 1 Recruiting
24 enrolled
iCaRe2
Recruiting
999,999 enrolled
ODYSSEY
Phase 4 Recruiting
2,076 enrolled
ACTION-1
Phase 3 Recruiting
288 enrolled
FARINET
Recruiting
450 enrolled
DENUTNE
Recruiting
100 enrolled
KinLET
Phase 1 Recruiting
20 enrolled
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/2 Recruiting
27 enrolled
ELEGANCE
Phase NA Recruiting
60 enrolled
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
Phase 1/2 Recruiting
260 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Phase 1 Recruiting
67 enrolled
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Phase NA Recruiting
120 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 2 FDA
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Phase 2 Recruiting
240 enrolled
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Phase NA Recruiting
200 enrolled
TAILOR-EUS
Recruiting
12,000 enrolled
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Recruiting
20 enrolled
TARGETMONITO
Phase NA Recruiting
330 enrolled
Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
Phase NA Recruiting
100 enrolled
ANZ UGI
Recruiting
500 enrolled
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
Phase 2 Recruiting
43 enrolled
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Phase 1/2 Recruiting
25 enrolled
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Recruiting
750 enrolled
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Phase 2 Recruiting
21 enrolled
SAUNA
Phase 4 Recruiting
270 enrolled
ETNA-FPG
Recruiting
650 enrolled
SEPTRALU
Recruiting
5,000 enrolled